DUKE WILLIAM E. (Chief Financial Officer) received a stock award from APEXIGEN, INC.
Compensation award — not an open‑market transaction. Less informative as a directional signal.
A · 1 award
Filed: 5/25/2023ACC: 0001209191-23-032167
Officer· Chief Financial Officer
Since Jul 2022
+132.74K
Net shares
Net buyer
$6.9K
Total sold
0
Open market trades
0B · 0S
2
Total transactions
150K acquired · 17.26K disposed
Non-Derivative Transactions2
Common Stock
Direct
Shares
+150K
Price / share
—
Trade value
—
% of position
572.9%
5/23/2023
26.18K→176.18K
Common Stock
Direct
Shares
−17.26K
Price / share
$0.40
Trade value
$6.90K
% of position
9.8%
5/23/2023
176.18K→158.92K
Total
Net shares
+132.74K
Net value
-$6.90K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 5/23/2023 | A · Award | +150K | — | — | 572.9% | 26.18K | 176.18K |
| Common Stock Direct | 5/23/2023 | F · Tax Withholding | −17.26K | $0.40 | $6.90K | 9.8% | 176.18K | 158.92K |
| Total | +132.74K | -$6.90K | ||||||
Derivative Transactions0
No derivative transactions reported